Polymorphisms in NFKB1 that diminish its expression have been linked to human inflammatory diseases and increased risk for epithelial cancers. The underlying mechanisms are unknown, and the link is perplexing given that NF-kB signaling reportedly typically exerts pro-tumorigenic activity. Here we have shown that NF-kB1 deficiency, even loss of a single allele, resulted in spontaneous invasive gastric cancer (GC) in mice that mirrored the histopathological progression of human intestinal-type gastric adenocarcinoma. Bone marrow chimeras revealed that NF-kB1 exerted tumor suppressive functions in both epithelial and hematopoietic cells. RNA-seq analysis showed that NF-kB1 deficiency resulted in aberrant JAK-STAT signaling, which dysregulated expression of effectors of inflammation, antigen presentation, and immune checkpoints. Concomitant loss of STAT1 prevented these immune abnormalities and GC development. These findings provide mechanistic insight into how polymorphisms that attenuate NFKB1 expression predispose humans to epithelial cancers, highlighting the pro-tumorigenic activity of STAT1 and identifying targetable vulnerabilities in GC.
In Brief
The links between NF-kB signaling, inflammation, and tumorigenesis are poorly understood. O'Reilly et al. reveal that NF-kB1 deficiency causes gastric cancer by dysregulating inflammation and immune checkpoints through a STAT1-dependent process. This may explain how polymorphisms in NFKB1 that impair its expression predispose to the development of epithelial cancers.
SUMMARY
Polymorphisms in NFKB1 that diminish its expression have been linked to human inflammatory diseases and increased risk for epithelial cancers. The underlying mechanisms are unknown, and the link is perplexing given that NF-kB signaling reportedly typically exerts pro-tumorigenic activity. Here we have shown that NF-kB1 deficiency, even loss of a single allele, resulted in spontaneous invasive gastric cancer (GC) in mice that mirrored the histopathological progression of human intestinal-type gastric adenocarcinoma. Bone marrow chimeras revealed that NF-kB1 exerted tumor suppressive functions in both epithelial and hematopoietic cells. RNA-seq analysis showed that NF-kB1 deficiency resulted in aberrant JAK-STAT signaling, which dysregulated expression of effectors of inflammation, antigen presentation, and immune checkpoints. Concomitant loss of STAT1 prevented these immune abnormalities and GC development. These findings provide mechanistic insight into how polymorphisms that attenuate NFKB1 expression predispose humans to epithelial cancers, highlighting the pro-tumorigenic activity of STAT1 and identifying targetable vulnerabilities in GC.
INTRODUCTION
Gastric cancer (GC) is a leading cause of human malignancyrelated deaths, with an often late-stage diagnosis that limits therapeutic options (Torre et al., 2015) . Most GCs are adenocarcinomas, classified into two distinct histological subtypes: the diffuse-type and the more common intestinal-type (IGC) (Correa, 1992) . IGC evolves over decades through a succession of histopathological stages, commencing with chronic superficial gastritis that progresses to mucosal atrophy, intestinal metaplasia, and increasingly severe dysplasia that culminates in invasive metastatic adenocarcinoma (Correa, 1992) . High dietary salt intake (Joossens et al., 1996) and chronic microbial infection of the gastric mucosa, particularly by Helicobacter pylori (H. pylori), constitute major risk factors for IGC (Suerbaum and Josenhans, 2007) . However, H. pylori infection does not inevitably lead to malignant disease, given that $50% of the global population are infected with H. pylori (Suerbaum and Josenhans, 2007) but fewer than 2% develop GC (Wroblewski et al., 2010) .
Polymorphisms in human NFKB1 that diminish its expression have been linked to inflammatory diseases and increased risk of epithelial cancer (Karban et al., 2004; Lewander et al., 2007) , although the mechanism by which this occurs is unclear. NF-kB-dependent gene expression is controlled by transcription factors comprising dimers of five related subunits: p50NF-kB1 (encoded by the NFKB1 gene), RelA, RelB, c-Rel, and p52NF-kB2. Heterodimers of p50NF-kB1 or p52NF-kB2 with RelA, c-Rel, or RelB, typically function as positive regulators of gene expression. Conversely, p50NF-kB1 and p52NF-kB2 homodimers, which lack intrinsic transcriptional trans-activating capacity, reportedly inhibit or promote transcription depending on cellular context, such as availability of interacting co-factors (Cao et al., 2006; Elsharkawy et al., 2010; Smale, 2012) . In unstimulated cells NF-kB factors are kept in check in the cytoplasm by binding to I-kB inhibitory proteins. Diverse extracellular signals that engage an I-kB kinase (IKK) complex phosphorylate the inhibitory I-kB proteins and thereby prime them for proteasomal degradation. This allows NF-kB factors (e.g., p50NF-kB1/ RelA heterodimers) to enter the nucleus where they control the transcription of target genes that regulate numerous functions in diverse cell types, including lymphoid, myeloid, and epithelial cells (Karin, 2009; Pasparakis, 2009) .
Dysregulated NF-kB signaling is generally viewed as protumorigenic (Karin, 2009) , modulating tumor promoting functions within nascent neoplastic cells as well as their microenvironment. Thus, it might appear counter-intuitive that polymorphisms that reduce NFKB1 expression predispose to cancer. It is noteworthy that the distinct functions exerted by specific NF-kB proteins during the initiation and progression of neoplastic disease remain poorly defined. In the case of gastric pathology driven by H. pylori infection, the complexity of NF-kB signaling is highlighted by the contrasting impacts that the conditional deletion of the IKK subunit, IKKb has in epithelial versus myeloid cells (Shibata et al., 2010) . IKKb deficiency in the gastric epithelium was shown to exacerbate inflammation and increase pre-neoplastic lesions, whereas myeloid cell-specific loss of IKKb diminished gastric atrophy.
Here we provide evidence that NF-kB1 functions as a tumor suppressor in GC. Our findings reveal that loss of NF-kB1 results in aberrant STAT1 activation, which triggers sterile inflammation as well as enhanced antigen presentation and immune checkpoint expression. These observations identify a link between loss of NF-kB, aberrant STAT1 activation, immune dysregulation and cancer and thereby provide mechanistic insight into how polymorphisms that attenuate Nfkb1 expression might predispose humans to epithelial cancers.
RESULTS
NF-kB1-Deficient Mice Develop Intestinal-Type Gastric Adenocarcinoma Mice lacking p50/p105-NF-kB1 (Nfkb1 À/À ) have initially been described as being healthy up to 1 year of age (Sha et al., 1995) . However, recent studies report that Nfkb1 À/À mice present with systemic inflammation, thought to cause early onset aging and mild multi-organ autoimmunity (de Valle et al., 2016; Jurk et al., 2014) . We found that Nfkb1 À/À mice developed gastric pathology from 6 months of age, first presenting with diffuse gastritis in the antrum and corpus of the gastric pits, with focal aggregates in the lamina propria, submucosa, and subserosa ( Figures 1A-1E , S1A 1K ) and penetration of the muscularis mucosae were also common (Figures 1L and 1M) . Typically, deeply invasive glands formed dilated cysts and this abnormality progressed to malignant tumors that could penetrate the muscularis mucosae (invasion), eliciting a fibroblastic stromal reaction ( Figures 1M-1O ). Metaplastic transformation was verified by the presence of neutral and acidic mucus-producing cells ( Figure 1P ), the loss of Muc5ac and elevation of Muc4 expression, without changes in Muc2 and (B) Representative photo-micrographs of H&E stained sections of glandular stomachs from 6-month-old Nfkb1 À/À and WT mice. Arrows = lymphocyte infiltration.
(C) Chronic gastritis scores from Nfkb1 À/À and WT mice of varying ages, mean ± SEM, **p = 0.016, ***p = 0.0001, ****p < 0.0001.
(D and E) Representative images of H&E stained gastric tissue sections from Nfkb1 À/À mice showing (D) normal gastric body mucosa mucosal architecture at 3 months and (E) pathological changes at 16 months exemplified mucosal thickening, foveolar architecture disorganization, elongated and/or branching gastric pits, plus abnormally increased epithelial proliferation; all reminiscent of superficial regenerative atypia (black arrows) with intraepithelial lymphocytes (arrowheads) and dilated dysplastic crypts (asterisk).
(F) Macroscopic images of stomachs from 26-month-old Nfkb1 À/À and WT mice. Arrowheads = gastric lesions, f = fundus, b = body, a = antrum.
(G) Kaplan-Meier curves of incidence of gastric disease (score > 1 for dysplasia or regenerative atypia or invasion) in Nfkb1 À/À and WT mice (p < 0.0001 for
(H-J) Graphical depiction of pathology scores: (H) gastric atrophy (mean ± SEM. *p < 0.05, ****p < 0.0001); (I) focal and diffuse dysplasia (mean ± SEM, *p < 0.05, **p < 0.01); (J) GC invasion (mean ± SEM. *p < 0.05, ***p < 0.006, ****p < 0.0001). Figure 2C) . This coincided with the expression of ICAM1, the ligand for the integrins LFA-1 (CD11a) and MAC1 (CD11b) that facilitates entry of activated leukocytes into tissues, being elevated in the gastric mucosa ( Figure 2D ). The gastric lesions in Nfkb1 À/À mice also showed marked expression of the proinflammatory mediators Ptgs2 and osteopontin ( Figures S2A-S2C ), and the metalloproteases MMP7, À9 and À13, the latter mostly at the invasive front of GC ( Figure S2D ). These findings reveal that the GC in Nfkb1 À/À mice exhibit characteristic markers of human IGC, some of which are predictors for metastasis and poor patient prognosis (Wu et al., 2007) . These results demonstrate that NF-kB1 exerts tumor suppressive functions within both gastric epithelial cells and hematopoietic cells.
Gastric Cancer Development in NF-kB1-Deficient Mice
Is not Accelerated by Helicobacter Infection, High Salt Diet, or Commensal Microorganisms Given that infection with H. pylori or a high salt diet are major risk factors for IGC in humans (Joossens et al., 1996) , we investigated the impact of these agents on GC development in Nfkb1 À/À mice.
Although infection with H. felis, a surrogate for H. pylori , caused gastric pathology in WT and Nfkb1 À/À mice, this did not accelerate GC development in the latter ( Figures  S3A-S3D) . A high-salt diet also had no overt impact on the devel- Changes in Active NF-kB Complexes Resulting from the Loss of NF-kB1 only Occur Late in GC Development p105NF-kB1 is not only the cytoplasmic precursor of p50NF-kB1 but can also stabilize Tpl2 , a Map3 kinase activator of Erk signaling in cells exposed to microbial or inflammatory stimuli (Dumitru et al., 2000) . Since Tpl2 has been implicated in tumor suppression (Gkirtzimanaki et al., 2013; Koliaraki et al., 2012) , we examined whether loss of NF-kB1 may cause GC through effects on Tpl2. However, aged Tpl2 À/À mice did not display detectable gastritis, atrophy, or dysplasia ( Figures  S4A-S4C ). This demonstrates that IGC development in Nfkb1 À/À mice is not a consequence of the impact of the loss of p105NF-kB1 on Tpl2, but must be driven by aberrations in NF-kB signaling. We therefore investigated how the composition of activated NF-kB proteins in the nucleus of gastric epithelial cells was affected by the loss of NF-kB1. Using gel shift analysis, a complex with mobility commensurate of NF-kB1 homodimers was the only NF-kB factor in the nuclei from gastric epithelial cells of 8-to 10-week-old WT mice. Predictably, this complex was absent from cells from Nfkb1 À/À animals ( Figure 4A ). Supershifts using antibodies against distinct NF-kB members confirmed that the nuclear (active) NF-kB complexes in WT cells were mainly composed of NF-kB1 homodimers, although a small amount of NF-kB2 homodimers could also be detected, but no NF-kB complexes containing RelA or c-Rel were observed (Figure 4B ). NF-kB activity was also reduced in resting and mitogenstimulated T cells as well as myeloid cells from Nfkb1 À/À mice when compared to those from WT animals ( Figure S4D ). The observation of nuclear phospho-RelA (i.e., activated RelA) in advanced human GC (Sasaki et al., 2001 ) prompted us to stain for p-RelA in stomachs from Nfkb1 À/À mice. In mice with established disease we detected nuclear p-RelA in localized clusters within dysplastic gastric glands (Figures 4C, S4E and S4F) . By contrast, gastric glands from pre-cancerous 3-month-old Nfkb1 À/À and WT mice only displayed a predominantly cytoplasmic pattern for p-RelA (i.e., not activated RelA) staining ( Figure 4D) . To determine what properties of gastric epithelial cells might be altered by the absence of NF-kB1 during disease initiation, division and survival of gastric epithelial cells were compared between young Nfkb1 À/À and WT mice at steady state and following exposure to stress (g-irradiation). Untreated Nfkb1
mice displayed an increase in gastric epithelial cell proliferation, and this was sustained 24 hr after g-irradiation ( Figure 4E ). Moreover, Nfkb1 À/À mice presented with a significant increase in epithelial cell death during the immediate recovery period following g-irradiation, although no differences to WT mice Please also see Figure S4 .
were seen at steady-state ( Figure 4F ). These observations suggest that the propensity for increased epithelial cell turnover after exposure to stress may be a contributing factor to the development of GC in Nfkb1 À/À mice.
To uncover possible consequences of the elevated RelA activity observed in advanced GC in the Nfkb1 À/À mice ( Figure 4D) and in human GC (Sasaki et al., 2001) , we used RNA interference to assess the impact of RelA silencing in the human GC-derived cell lines, AGS and MKN28. Although RelA silencing did not affect cell survival or proliferation (not shown), it significantly decreased the invasive capacity of both GC cell lines ( Figures  4G and 4H ). These results suggest that increased RelA activity may drive the invasive phenotype of GC in advanced disease. (Wu et al., 2010) revealed that the genes upregulated in all these cell types were enriched for inflammatory mediators, including cytokines and chemokines, with many of them known NF-kB targets (e.g., TNF-a, IL-1b, IL-6, Tap1, ICAM1, CD44; Figures 5A-5C ). KEGG pathway analysis revealed that antigen processing and presentation, innate immune signaling (Toll-like, RIG1-like) and JAK-STAT signaling were the main processes upregulated in the gastric cell populations from the Nfkb1 À/À mice (Tables   S4-S6 ). Volcano plots (log 10 [fold change] versus -log 10 [adjusted p value]) show expression changes for individual genes within these pathways ( Figures 5D-5N ). In gastric epithelial cells from Nfkb1 À/À mice, this display format illustrates increased expression of genes that function in antigen processing and presentation (B2 m, Tap1, Tap2, Cd74, , innate immune signaling (Tlr2, RigI, Nlrc5, , and JAK-STAT signaling (Stat1, Stat2, Socs1, and Jak3) ( Figures 5D-5F , Table S1 ). Lymphoid cells from the stomachs of Nfkb1 À/À mice also showed marked upregulation of genes involved in antigen presentation, cell adhesion-migration, and chemokines (Tap1, Tap2, B2 m, Ccl4, Cxcr4; Figures 5G-5J , Table S2 ). In the myeloid cells from the stomachs of Nfkb1 À/À mice, the expression of genes encoding pro-inflammatory cytokines-chemokines (Tnf, IL-1b) and the inflammasome (e.g., Nlrp3) were significantly increased ( Figures 5K-5M , Table S3 ). Many of these genes, particularly those dysregulated in the myeloid cells from the Nfkb1 À/À mice, are known to be induced by JAK-STAT signaling ( Figure 5N ). There was also a notable induction of genes associated with immune checkpoint signaling, including Cd274, in both myeloid and epithelial cells as well as Ctla4 and Pdcd1 in lymphoid cells from the stomachs of the Nfkb1 À/À mice ( Figure 5O ). We next proceeded to validate findings from the RNA-seq analyses at the protein level. We found that both MHC class I and class II were elevated in epithelial and myeloid cells from the stomachs of $4 month-old Nfkb1 À/À mice when compared to those from WT animals ( Figure 6A ). Moreover, in established GC we found increased expression of Nlrc5 and Ciita, the master regulators of MHC class I and class II gene expression, respectively ( Figure 6B ). Elevated expression of Tap1 and B2m mRNA were detected in the gastric antrum of aged Nfkb1 À/À mice (Figure 6B) . MHC expression on antigen-presenting cells (APCs) and pre-malignant epithelial cells can be an indicator of inhibitory immune checkpoint signaling, particularly when accompanied by an upregulation of PD-L1 (CD274) on APCs and PD1, CTLA4 (CD152), or LAG3 on T cells (Brahmer et al., 2012) . We investigated this further, and while no change in PD-L1 expression was detected on gastric epithelial cells from 3 month-old Nfkb1 À/À mice compared to WT controls, PD-L1 was clearly elevated on certain myeloid cells from the stomachs in the former ( Figure 6C ). This included resident MAC-1 + Ly6C Figure S5A ). At $17 months when malignant disease had become established in Nfkb1
mice, the expression of PD-L1 was also increased on transformed epithelial cells ( Figure 6D ). Collectively, these findings demonstrate that the absence of NF-kB1 dysregulates signaling networks that control inflammation, antigen presentation and immune checkpoints, with many of the affected genes known to be controlled by JAK-STAT signaling. Moreover, these results show that in Nfkb1 À/À mice aberrations in immune checkpoints are an early event in GC development that are further exacerbated in established disease.
Aberrant STAT Activation Promotes GC Development in
The dysregulation of STAT and NF-kB signaling frequently cooccur in solid cancers, with IL-6 being the link between these pathways (He and Karin, 2011) . We found that the T and/or myeloid cells but not the epithelial cells from the gastric mucosa of 3-month-old pre-cancerous Nfkb1 À/À mice were capable of producing high expression of IL-6, TNF-a, IFN-g, IL-17A, and IL-22 ( Figures S5B and S5C) . Elevated IL-6, TNF-a, IFN-g, and IL-17A produced by leukocytes were also seen during established gastric disease in Nfkb1 À/À mice ( Figure S5D ). This identifies these factors as likely key contributors to a pro-inflammatory environment. Moreover, IL-1b, IL-6, and IL-11, cytokines commonly linked to human IGC (Sugimoto et al., 2010) , were also found to be significantly elevated in the GC lesions from Nfkb1 À/À mice ( Figure S5E ).
The abnormally increased Stat1 and Stat3 mRNA expression in the gastric mucosa of Nfkb1 À/À mice ( Figure 5 , Tables S1-S3), combined with the knowledge that inflammatory cytokines produced by T cells and myeloid cells can activate JAK-STAT signaling (Villarino et al., 2017) , prompted an examination of the impact of NF-kB1 deficiency on basal and cytokineinduced JAK-STAT signaling. In untreated gastric epithelial cells from Nfkb1 À/À mice, p-STAT3 staining, indicative of activated STAT3, was comparable to that seen in WT cells, whereas a sub-population in the former displayed increased p-STAT1 (i.e., activated STAT1, Figure S5F ). Treatment with IFN-g augmented p-STAT1 expression to a similar extent in gastric epithelial cells of both genotypes ( Figure S5F ). T cells from the stomachs of Nfkb1 À/À mice, but not those from WT controls, contained a small sub-population displaying activated STAT1 as well as activated STAT3, but the activity of these STATs increased to a similar extent in T cells of both genotypes after treatment with IL-6 and to a lesser extent after stimulation with IFN-g ( Figure S5G ). Comparable basal as well as cytokine induced STAT1 and STAT3 activity were seen in myeloid cells from the stomachs of WT and Nfkb1 À/À mice ( Figure S5H ). These data show that the absence of NF-kB1 causes an increase in the basal, but not the cytokine induced activation of STAT1, presumably because even young Nfkb1 À/À mice have increased expression of cytokines that are known to drive JAK-STAT signaling. Bioinformatic analysis was used to further understand the impact of NF-kB1 loss on STAT1 and STAT3-dependent gene expression. Notably, genes known to be regulated by both STAT1 and NF-kB transcription factors were prominent among the genes aberrantly expressed in each of the cell types from the stomachs of Nfkb1 À/À mice that we had tested. Among the NF-kB-only regulated genes, 16% and 60%, respectively, were aberrantly expressed in epithelial and myeloid cells from the stomachs of Nfkb1 À/À mice ( Figure 7A ). The impact of NF-kB1 deficiency on the expression of STATonly regulated genes, or STAT plus NF-kB co-regulated genes varied between cell types (for STAT1-only targets: 49% in myeloid, 23% in lymphoid, and 5% in epithelial cells) ( Figure 7A ). Consistent with the data from the RNAseq analysis, the total STAT1 expression progressively increased in the gastric antrum of Nfkb1 À/À mice with age, whereas expression of activated STAT3 was only slightly elevated in the gastric antrum of Nfkb1 À/À mice ( Figure 7B ).
These findings indicate that aberrant STAT signaling may contribute to GC development in Nfkb1 À/À mice.
To test this hypothesis, we crossed Nfkb1 À/À mice with genetically targeted
Gp130
Y757F mutant mice, which carry an a Y757F amino acid substitution in the gp130 common receptor chain for IL-6, IL-11, and OSM, that results in IL-6 family cytokine-dependent hyper-activation of STAT1 and STAT3 (Jenkins et al., 2005) . Homozygous mutant Gp130 Y757F/Y757F mice develop non-invasive gastric adenomas from 4 weeks of age, whereas Gp130 Y757F/+ heterozygotes only exhibit mild gastritis (Jenkins et al., 2005; Putoczki et al., 2013) . We found that , or Nfkb1 À/À animals at this young age ( Figure 7C ). Gastritis and invasive cancer also occurred in Nfkb1 À/À Gp130 Y757/+ mice significantly earlier than in Nfkb1 À/À animals ( Figures 7D-7E,   S6B ). This coincided with the earlier onset of the abnormal increase in IL-1b, IL-2, IL-17A, CCL2, CCL3, CCL4, CCL5, and TNF in the serum of the Nfkb1 À/À Gp130 Y757/+ mice ( Figure S6C ). Collectively, these findings demonstrate that loss of NF-kB1 and aberrant STAT activation cooperate to cause severe gastritis and IGC. (H) Bottom graph shows gastric pathology scoring of the 12-month-old mice shown in (G); top graph shows gastric pathology scoring mice of 6-month-old mice of the indicated genotypes (n = 3-6 mice per genotype). ****p < 0.0001, ***p0.0005, **p < 0.1, *p < 0.5. Please also see Figure S6 and S7.
Loss of STAT1 Prevents GC Development in
À/À mice and because aberrant STAT1 and STAT3 activation were observed in several cell types in precancerous Nfkb1 À/À mice, we tested whether STAT1 and/or STAT3 were essential for the development of gastric pathology in Nfkb1 À/À mice ( Figures 7F-7H ). We utilized published Stat3 +/À mice to produce Nfkb1
Stat3
+/À animals (note that complete loss of Stat3 causes embryonic lethality; Takeda et al., 1997) and used CRISPR/Cas9 technology to generate Nfkb1
Stat1
+/À and Nfkb1
The loss of STAT1 was verified at both the gene ( Figure S7A ) and protein level (Figure 7F) . We found that the loss of one allele of Stat3 did not prevent the formation of macroscopic GC lesions, although it did slightly reduce gastritis in Nfkb1 À/À mice ( Figures 7G-7H , S7B). Loss of one allele of Stat1 also did not have any impact on GC pathology (data not shown), but the complete absence of STAT1 blunted all gastric pathology in Nfkb1
mice for up to at least one year of age ( Figures 7G-7H, S7B) . Notably, the loss of STAT1 caused a reduction in PD-L1 expression in myeloid cells of 3 month-old Nfkb1 À/À mice ( Figure S7C ).
These findings reveal that STAT1 has a critical pro-tumorigenic function in GC and in activating immune checkpoint regulators. This establishes a direct link between loss of NF-kB1, aberrant activation of pro-tumorigenic functions of STAT1, and increased expression of immune checkpoint regulators.
DISCUSSION
Excessive NF-kB activation is considered a hallmark of inflammation-associated cancers (Karin, 2009) . H. pylori infection triggers NF-kB activation in the gastric mucosa, and this is perpetuated by inflammatory factors produced by infiltrating immune cells, thereby fueling tumor initiation (Glocker et al., 1998) . These findings helped shape the concept that excessive NF-kB transcription factor activity can exert potent pro-tumorigenic functions (Naugler and Karin, 2008) . Although this concept is not challenged here, we have demonstrated a critical tumor suppressive function for the NF-kB family member, NF-kB1, acting both within epithelial and immune cells. Notably the development of GC driven by loss of NF-kB1 depended on STAT1 activation and was associated with heightened inflammation and increased expression of immune checkpoint regulators. Our observation that Nfkb1 haplo-insufficiency can lead to GC in mice shows that even a 50% reduction in NF-kB1 protein levels can precipitate cancer. This is of relevance to human cancer, given that NFKB1 polymorphisms that are associated with reduced NF-kB1 expression are linked to epithelial cancers (Lewander et al., 2007; Li et al., 2013) , gastric cancer (Arisawa et al, 2013 , Chen et al, 2015 , Hua et al, 2014 , Li et al, 2017 , Lu et al, 2012 , Sunakawa, et al, 2015 autoimmune diseases (Karban et al., 2004) . The best characterized of these polymorphisms is located in the promoter of the human NFKB1 gene (rs28362491, À94 insertion-deletion ATTG polymorphism), where the del allele is associated with a heightened risk of certain epithelial cancers (Karban et al., 2004; Lewander et al., 2007; Li et al., 2013) . Our observation that NF-kB1 needs to be absent from both the gastric epithelial and hematopoietic compartments to cause GC in mice is consistent with the notion that the ubiquitous reduction in NF-kB1 activity associated with the aforementioned NFKB1 polymorphisms increases the risk of epithelial cancers in humans.
No compensatory upregulation of the activity of other NF-kB factors was seen in young pre-cancerous Nfkb1 À/À mice. It therefore appears that loss of p50NF-kB1 homodimers, rather than upregulation of other NF-kB factors, is critical for triggering gastric inflammation and IGC development. This conclusion is supported by the finding that mice carrying a point mutation in Nfkb1 that prevents the formation of p50NF-kB1 homodimers but does not prevent the formation of NF-kB1 heterodimers develop low-grade multi-organ inflammation and autoimmune disease (Wilson et al., 2015) . GC was not reported in this mouse strain, but this might be due to the relatively short period of their observation. Although p50NF-kB1 homodimers lack intrinsic transcriptional trans-activating capacity, they are able to promote transcription through interactions with the atypical I-kB proteins BCL3 and I-kBz (Oeckinghaus and Ghosh, 2009; Watanabe et al., 1997) . Conversely, DNA bound NF-kB1 homodimers have been reported to recruit HDAC1, thereby blocking the transcription of certain NF-kB target genes (Elsharkawy et al., 2010) . Indeed, the increased activity of interferon (IFN) regulated pathways, including the STAT1 activation that we observed in the Nfkb1 À/À mice, might in part be explained by the loss of p50NF-kB1 homodimer-mediated repression of a subset of IFN-inducible genes. This repression involves p50NF-kB1 homodimers competing with the interferon regulatory factors, IRF3 and ISGF3, for a guanine-rich subclass of interferon regulatory elements (G-IRE) (Cheng et al., 2011 ). It appears likely that disruption of both modes of NF-kB1-mediated transcriptional control contribute to the development of GC in the Nfkb1 À/À mice.
The elevated expression of genes and proteins involved in cytokine or chemokine activated signaling and antigen presentation are likely to promote gastric inflammation in Nfkb1 À/À mice.
Notably, our data are in agreement with the finding that blocking canonical NF-kB signaling in hepatocytes using conditional Ikkb gene targeting, increased the expression of a common set of antigen-presentation genes in hepatocytes (Maeda et al., 2005) and gastric epithelial cells (Shibata et al., 2010) . This suggests that a cell intrinsic NF-kB1-regulated mechanism might operate to limit antigen presentation. Anti-tumor immune responses by tumor infiltrating lymphocytes (TILs) can be suppressed when malignant cells express the ligands for immune checkpoint regulators expressed on CD8 + cytotoxic T cells (e.g., CTLA-4, PD1). This facilitates immune escape and consequently enhanced growth of cancers (Pardoll, 2012) . Accordingly, the development of immune checkpoint blocking therapeutics (e.g., antibodies targeting CTLA4, PD1, or PD-L1) that boost the cytotoxic activity of tumor antigen-specific T cells have improved survival outcomes for a proportion of patients with melanoma, non-small cell lung cancer, and renal carcinoma (Page et al., 2014) . Notably, PD-L1 is expressed on many human gastric tumors (Qing et al., 2015) and amplification of the genes encoding PD-L1 or the related PD-L2 are found in the Epstein-Barr Virus (EBV)-positive GC subtype (Cancer Genome Atlas Research Network, 2014), a cancer that is characterized by aberrant NF-kB activation. Our data show that in GC driven by loss of NF-kB1 function, PD-L1 upregulation is an early event in the myeloid cells in the stomach. This supports the notion that immune evasion is an attribute that must be acquired early during inflammation driven GC development. The expression of PD-L1 on neoplastic cells during advanced stages of GC in Nfkb1 À/À mice suggests a potential therapeutic opportunity for patients with advanced GC (Fuchs et al., 2017) . NF-kB activation and STAT signaling are both recognized as important drivers of inflammation-associated cancers. Our gene-expression data and functional analyses reveal that loss of NF-kB1 cooperates with aberrant STAT activation to promote the development of gastritis and GC. Both STAT3 and STAT1 are implicated in diverse human cancers. Although STAT1 is generally considered to function as a tumor suppressor (Szelag et al., 2015) , recent evidence indicates that in certain instances, STAT1 can also act as a tumor promotor (Meissl et al., 2017) . Our results reveal that in the stomach PD-L1 upregulation is driven by aberrant STAT1 activation. This provides a functional link between loss of NF-kB1, aberrant STAT1 activation, increased PD-L1 expression, and GC development. The loss of STAT1 prevented gastritis, GC, and aberrant PD-L1 expression in Nfkb1 À/À mice. Loss of one allele of Stat3 had only minor impact, but we cannot rule out the possibility that complete loss of STAT3 might also be able to prevent gastric disease in Nfkb1 À/À mice (but this cannot be easily tested due to the embryonic lethality of Stat3 À/À mice).
In conclusion, our findings suggest a rationale for immune checkpoint therapies, not only at advanced stages of GC (Fuchs et al., 2017) but also in early stage disease. Our findings also suggest that the benefits of such immune checkpoint therapies might be enhanced by the addition of inhibitors of JAK-STAT signaling or antagonists of cytokines or their receptors.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: Irradiation with 14 Gy was performed without subsequent hematopoietic reconstitution. Some of the mice that had been exposed to 14 Gy gÀirradiation, were injected intraperitoneally (i.p.) with BrdU (50 mg/kg body weight; Sigma) 2 h prior to sacrifice.
differences in quality between the RNA samples when necessary to increase statistical power (Ritchie et al., 2006) . Differential gene expression between cells from Nfkb1 À/À versus WT mice was assessed using empirical Bayes moderated t-statistics allowing for an abundance trend in the standard errors and for robust estimation of the Bayesian hyper-parameters . The Benjamini and Hochberg method was used to control the false discovery rate below 5%.
GENE SET TESTING AND PATHWAY ANALYSIS
KEGG pathways for mouse were downloaded from http://bioinf.wehi.edu.au/software/MSigDB. A list of human NF-kB target genes was downloaded from the Boston University Gilmore Lab (http://www.bu.edu/nf-kb/gene-resources/target-genes) and a subdivision of these targets were identified as genes encoding cytokines/chemokines or their modulators. A list of STAT1 ChIP-Seq-based human target genes was obtained from the Table S1 published in (Satoh and Tabunoki, 2013 ) and a list of human genes regulated by STAT3 were extracted from Table 1 published in Carpenter and Lo (2014) . Human genes were mapped to mouse homologs using the Jackson Laboratory mouse-human ortholog table downloaded December 2012 and the NCBI mouse-human homolog table downloaded April 2015. Enrichment of KEGG pathways and NF-kB target genes in the differential gene expression results were evaluated using rotation gene set testing (ROAST) (Wu et al., 2010) with 10,000 rotations
STATISTICAL ANALYSIS
Statistical analysis was performed using the Student's t test or paired Student's t test, where indicated, log rank (Mantel-Cox) test for survival curves, one-way analysis of variance using Tukey's comparison test to compare multiple groups or Mann Whitney test where appropriate and indicated.
